Adaptive Biotechnologies Corp share price logo

Adaptive Biotechnologies Corp Share Price

NASDAQ: ADPT

Mid Cap

$14.58

+0.11

(+0.76%)

as on

Adaptive Biotechnologies Corp Stock Performance

as on April 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $14.12
    $14.86
    downward going graph

    3.16%

    Downside

    1.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.77
    $20.76
    downward going graph

    53.53%

    Downside

    42.39%

    Upside

    downward going graph

Adaptive Biotechnologies Corp share price movements today

Previous Close
$14.47
Open
$14.25
Volume
1.3M
Day's Low - High
$14.12 - $14.86
52 Week Low - High
$6.77 - $20.76

Adaptive Biotechnologies Corp Historical Returns

1 Month Return
+ 6.55 %
3 Month Return
-19.03 %
1 Year Return
+ 97.41 %
3 Year Return
+ 73.71 %
5 Year Return
-64.09 %

Adaptive Biotechnologies Corp Stock Fundamentals & Key Indicators

Check Adaptive Biotechnologies Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.2B

EPS (TTM)

-0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-39.3M

Revenue (TTM)

277.0M

Profit Margin

-21.48%

Return On Equity TTM

-27.82%

Adaptive Biotechnologies Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adaptive Biotechnologies Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Adaptive Biotechnologies Corp image
Adaptive Biotechnologies Corp
BUY$2.2B-64.09%NA-21.48%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B127.64%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$112.2B100.4%28.8232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$37.2BNA131.655.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.4B48.8%18.0831.41%

Stock Returns calculator for Adaptive Biotechnologies Corp Stock including INR - Dollar returns

The Adaptive Biotechnologies Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Adaptive Biotechnologies Corp investment value today

Current value as on today

₹2,17,419

Returns

₹1,17,419

(+117.42%)

Returns from Adaptive Biotechnologies Corp Stock

₹98,909 (+98.91%)

Dollar Impact

₹18,511 (+18.51%)

Analyst Recommendation on Adaptive Biotechnologies Corp Stock

Based on 14 analysts

BUY

78.57%

Buy

21.43%

Hold

0.00%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Adaptive Biotechnologies Corp. Average target price of $20.57

Adaptive Biotechnologies Corp Share Price Target

Get share price movements and forecasts by analysts on Adaptive Biotechnologies Corp.

What analysts predicted

29.12%UPSIDE

Target Price

$20.57

Current Price

$14.58

Analyzed by

14 Analysts

Target

$20.57

Adaptive Biotechnologies Corp target price $20.57, a slight upside of 29.12% compared to current price of $14.58. According to 14 analysts rating.

Adaptive Biotechnologies Corp Stock’s Investor Sentiment and Interest

Search interest for Adaptive Biotechnologies Corp Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-55% versus previous 30 day period

Adaptive Biotechnologies Corp Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
37
45
41
43
46
47
52
58
93
71
Gross Profit
18
26
23
23
29
29
35
40
75
53
Operating Income
-50
-71
-48
-47
-32
-33
-29
-25
10
-12
EBITDA
-40
-61
-39
-38
-24
-26
-29
-18
16
-6
Interest Expense
3
3
2
2
2
2
2
2
2
2
Depreciation
5
5
5
5
4
4
4
4
4
4
Income Before Tax
-50
-69
-47
-46
-32
-33
-29
-25
9
-13
Income Tax Expense
-5
0
4
0
-
-
-
-
-
-
Net Income
-50
-69
-47
-46
-32
-33
-29
-25
9
-13
Net Profit Margin
-132.65%
-151.67%
-113.45%
-107.02%
-69.07%
-70.99%
-56.92%
-43.50%
10.16%
-18.94%

Adaptive Biotechnologies Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
38
55
85
98
154
185
170
178
276
Gross Profit
22
35
62
75
105
127
94
106
205
Operating Income
-44
-49
-78
-152
-208
-200
-227
-162
-57
EBITDA
-37
-43
-70
-144
-193
-175
-189
-128
-29
Interest Expense
-
-
-
-
1
4
13
11
11
Depreciation
5
6
7
8
13
20
22
19
17
Income Before Tax
-42
-46
-68
-146
-207
-200
-225
-159
-59
Income Tax Expense
0
3
-9
-6
-1
-57
0
-
-
Net Income
-42
-46
-68
-146
-207
-200
-225
-159
-59
Net Profit Margin
-111.40%
-83.44%
-80.65%
-148.63%
-134.30%
-108.03%
-132.29%
-89.12%
-21.48%

Adaptive Biotechnologies Corp Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-69
-47
-46
-32
-33
-29
-25
9
-13
Operating Cash Flow
-26
-38
-17
-27
-12
-28
-12
-7
2
Investing Cash Flow
3
44
5
5
22
25
3
17
-8
Financing Cash Flow
0
0
0
0
0
5
1
1
21
Change in Cash
-23
6
-11
-21
9
2
-7
11
15

Adaptive Biotechnologies Corp Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-46
-68
-146
-207
-200
-225
-159
-59
Operating Cash Flow
-32
205
-149
-192
-183
-156
-95
-45
Investing Cash Flow
0
-481
-117
181
2
129
77
37
Financing Cash Flow
1
319
293
27
132
2
0
30
Change in Cash
-30
43
26
15
-49
-24
-17
22

Global Institutional Holdings in Adaptive Biotechnologies Corp

Funds
Holdings
Ameriprise Financial Inc
3.88%
Amova Asset Management Americas, Inc
2.37%
Jennison Associates LLC
1.74%
ING Investment Management LLC
1.02%
D. E. Shaw & Co LP
1.24%
See all

Adaptive Biotechnologies Corp News & Key Events

  • img

    Today's Timeline - 15 December

    Mon, 07:23 PM

    -

    Adaptive Biotechnologies signs two deals with Pfizer, potentially earning up to $890 million for rheumatoid arthritis research.

Insights on Adaptive Biotechnologies Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ADPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ADPT stock has moved up by 111.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ADPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 9.54M → -13.57M (in $), with an average decrease of 242.3% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 93.97M → 71.68M (in $), with an average decrease of 23.7% per quarter

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
OrganisationAdaptive Biotechnologies Corp
Headquarters1165 Eastlake Avenue East, Seattle, WA, United States, 98109
IndustryBiotechnology
CEOMr. Chad M. Robins M.B.A.
E-voting on sharesClick here to vote

Key Management of Adaptive Biotechnologies Corp

Name

Title

Mr. Kyle Piskel

VP, CFO & Principal Accounting Officer

Mr. Francis T. Lo

Chief People Officer

Ms. Susan Bobulsky

Chief Commercial Officer of MRD

Mr. Chad M. Robins M.B.A.

Co-Founder, CEO & Chairman

Dr. Harlan S. Robins Ph.D.

Co-Founder & Chief Scientific Officer

Mr. Christopher Carlson Ph.D.

Founder

Ms. Karina Calzadilla

Vice President of Investor Relations

Ms. Clarice McCauley

Interim General Counsel, Corporate Secretary, VP & Chief Compliance Officer

Ms. Julie Rubinstein

President & COO

Dr. Sharon Benzeno Ph.D.

Chief Commercial Officer of Immune Medicine

FAQs

What is Adaptive Biotechnologies Corp share price today?

Adaptive Biotechnologies Corp share price today is $14.58 as on at the close of the market. Adaptive Biotechnologies Corp share today touched a day high of $14.86 and a low of $14.12.

What is the 52 week high and 52 week low for Adaptive Biotechnologies Corp share?

Adaptive Biotechnologies Corp share touched a 52 week high of $20.76 on and a 52 week low of $6.77 on . Adaptive Biotechnologies Corp stock price today i.e. is closed at $14.58,which is 29.77% down from its 52 week high and 115.21% up from its 52 week low.

What is Adaptive Biotechnologies Corp's market capitalisation today?

Adaptive Biotechnologies Corp market capitalisation is $0.00T as on .

How to invest in Adaptive Biotechnologies Corp Stock (ADPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adaptive Biotechnologies Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adaptive Biotechnologies Corp Shares that will get you 0.1029 shares as per Adaptive Biotechnologies Corp share price of $14.58 per share as on April 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Adaptive Biotechnologies Corp Stock (ADPT) from India?

Indian investors can start investing in Adaptive Biotechnologies Corp (ADPT) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in Adaptive Biotechnologies Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on Adaptive Biotechnologies Corp share’s latest price of $14.58 as on April 21, 2026 at 1:29 am IST, you will get 0.6859 shares of Adaptive Biotechnologies Corp. Learn more about fractional shares .

What are the returns that Adaptive Biotechnologies Corp has given to Indian investors in the last 5 years?

Adaptive Biotechnologies Corp stock has given -64.09% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?